Japanese Knotweed Allergy Shots: Invasive Weed With Minimal SCIT Evidence
Japanese knotweed (Reynoutria japonica) is one of the IUCN's 100 worst invasive species and has colonized all 48 contiguous US states — but it is primarily insect-pollinated by bees and flies, making airborne pollen exposure clinically negligible. Most 'knotweed allergy' presentations are contact dermatitis in invasive-removal crews, coincidental Polygonaceae family sensitization, or misattribution to the ragweed and goldenrod that bloom simultaneously in August–October.
Japanese Knotweed Allergy Immunotherapy: How It Works
Allergy immunotherapy is the only long-term treatment that re-trains the immune system to stop overreacting to japanese knotweed — rather than just masking symptoms with antihistamines or steroids. By gradually exposing the body to controlled doses of japanese knotweed allergen, immunotherapy shifts the underlying allergic response and produces relief that often outlasts treatment by 7–10 years.
There are two evidence-based forms of japanese knotweed immunotherapy used today, both built on the same desensitization principle but delivered very differently.
of sustained relief after a complete immunotherapy course — the only allergy treatment with proven long-term effect after stopping.
Allergy Shots (SCIT)
Weekly injections of japanese knotweed extract in a clinic, escalating over 3–6 months until a maintenance dose is reached. Continued monthly for 3–5 years. Longest clinical track record for japanese knotweed allergy.
- Strongest evidence base for severe and polysensitized patients
- Covered by most insurance plans
- Requires 50–100+ in-person clinic visits across the full course
Allergy Drops / Tablets (SLIT)
Daily drops or dissolvable tablets containing japanese knotweed extract, held under the tongue at home. Same desensitization principle, delivered without injections. WHO-recognized as an effective form of allergy immunotherapy since 2001.
- Taken at home — no weekly clinic trips, no needles
- Lower systemic reaction rate than allergy shots
- Curex offers prescription japanese knotweed immunotherapy drops with allergist oversight
The rest of this page goes deep on allergen-specific immunotherapy with shots — protocol, efficacy data, side effects, and cost. If you’d rather skip the clinic and treat japanese knotweed allergy with at-home drops, see how Curex sublingual immunotherapy compares below.
What is Japanese Knotweed?
The biology, taxonomy, and clinical fingerprint of Japanese Knotweed — the foundation of how SCIT targets it.
Reynoutria japonica in fall bloom — terminal panicles of small cream-white flowers pollinated by honeybees and bumblebees. The famous 'knotweed honey' confirms insect-pollination ecology. Pollen is not a clinically significant aeroallergen.
- Scientific name
- Reynoutria japonica (syn. Fallopia japonica, Polygonum cuspidatum)
- Family
- PolygonaceaeBuckwheat family
- Type
- Invasive shrub weed (insect-pollinated, not a significant aeroallergen)
- Native to
- Eastern Asia (Japan, China, Korea); invasive across North America and Europe
- Allergen proteins
- No formally named WHO/IUIS allergens for Reynoutria japonica (as of 2025)Stilbene compounds (resveratrol, emodin) in rhizomes are nutraceutical/research compounds — unrelated to pollen allergenicity
- Particle size
- N/A — pollen not significantly airborne
- Avoidance difficulty
- Moderate
How Japanese Knotweed Allergy Presents
Symptoms by body system — useful for distinguishing Japanese Knotweed sensitivity from overlapping allergies and infections.
Respiratory
- Rare rhinitis in the exceptional confirmed-IgE case — not a general-population aeroallergen concern
- August–October respiratory symptoms in knotweed-dense areas are almost invariably caused by ragweed and goldenrod blooming simultaneously
- Knotweed pollen is not significantly airborne — recent aerobiological studies (Severova et al. 2022) detect it only at low counts even near dense stands
- Invasive-removal workers face the greatest potential exposure through close plant contact during clearing operations
Ocular
- Rare conjunctivitis only in the exceptional confirmed-IgE case
- Most 'knotweed-season' ocular symptoms are from ragweed and goldenrod — the actual dominant fall aeroallergens
- Irritant ocular symptoms from clearing operations (dust, plant sap) are distinct from IgE-mediated allergy
Dermal
- Contact dermatitis in invasive-species removal crews and landscape workers clearing knotweed — stilbene compounds (resveratrol precursors) implicated (Iwashina et al. 2010 Biochem Syst Ecol)
- Localized urticaria from direct plant-sap contact in clearing workers
- Contact reaction is a chemical response — distinct from IgE pollen allergy
Systemic
- No systemic anaphylaxis documented from Japanese knotweed pollen aeroallergen exposure
- Resveratrol from knotweed rhizomes is a widely studied nutraceutical — unrelated to pollen allergy
- Invasive removal workers face physical hazards from bamboo-like hollow stems but not systemic IgE reactions
Japanese knotweed is one of the most frequently misidentified allergy culprits I encounter in northeastern and mid-Atlantic patients. The timing is August–October — exactly when ragweed is peaking — and knotweed is everywhere along river banks and roadsides. When I test these patients, it's ragweed almost every time. Knotweed is remarkable as an invasive plant; as an aeroallergen, it's essentially a bystander.
When & Where Japanese Knotweed Peaks
Allergen intensity by month and by state. Useful for timing SCIT start dates and travel planning.
12-Month Intensity
Bloom peak: August–October — coincides perfectly with ragweed season, making attribution confusion nearly universal· ~10 weeks of bloom; insect-pollinated pollen is not significantly airborne even during this period
US Exposure Map
7 high-intensity statesWhat Japanese Knotweed Cross-Reacts With
Patients sensitized to one allergen often react to others sharing similar proteins. This map shows the documented molecular overlaps.
Japanese knotweed cross-reactivity is essentially unstudied — no molecular allergen has been characterized. Family-level Polygonaceae cross-reactivity via pan-allergens is theoretically possible based on the Mari 2008 (J Investig Allergol Clin Immunol) pan-allergen framework, but unstudied for Reynoutria specifically.
Same Polygonaceae family; theoretical pan-allergen cross-reactivity — unstudied for Reynoutria
Is SCIT Right for Your Japanese Knotweed Allergy?
Answer five questions to clarify whether your fall symptoms might be from Japanese knotweed pollen (rare) or from ragweed and other fall allergens (much more likely).
When do your fall symptoms peak?
The Japanese Knotweed SCIT Protocol
Japanese knotweed SCIT uses a non-standardized Reynoutria japonica extract with very limited commercial availability. It is reserved for the rare confirmed case of IgE-mediated sensitization in invasive-removal crews. PPE and vegetation-management methods are the primary interventions.
Standard build-up using non-standardized knotweed extract if commercially available. Most allergists will not stock this extract given its rarity of indication — sourcing requires advance planning. The 30-minute post-injection observation period is mandatory.
Monthly maintenance for the confirmed occupational sensitization case. Co-occurring Polygonaceae allergens (dock, sorrel) may be combined in the same vial given family-level cross-reactivity. Evidence limitations require a shared decision-making framework with the patient.
After completing a full course, clinical reassessment of symptom burden guides continuation. The absence of RCT-validated outcome measures for knotweed SCIT means this assessment is largely empirical.
Extract Concentration Ladder
You progress through each vial during build-up. Concentration increases ~10x per step.
What the Research Shows for Japanese Knotweed SCIT
Japanese knotweed SCIT has zero published RCT evidence. The plant's insect-pollination biology makes aeroallergen exposure minimal, further limiting any rational basis for SCIT outside exceptional occupational scenarios.
- Published SCIT RCTs for Japanese knotweed monotherapy0%Systematic literature review through 2025 — zero published RCTs identified for Reynoutria japonica SCIT
- Ragweed SCIT symptom reduction (the far more likely fall allergen)85%Creticos PS, et al. 2006, NEJM 354:1401–1412 — the strongest evidence base for any US fall weed immunotherapy
Japanese knotweed SCIT evidence is absent. This page exists because patients search for knotweed allergy information — and the most important clinical service this page provides is redirecting them toward ragweed (Amb a 1) testing, which is almost certainly the true cause of their August–October symptoms.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Japanese Knotweed SCIT Side Effects
In the exceptional case where knotweed SCIT is pursued, it follows standard inhalant allergen safety protocols. With Curex's at-home program, your first dose and every dose increase are supervised live over Zoom by a board-certified allergist, with a prescribed epinephrine auto-injector confirmed on hand.
Local reactions
2 documentedSystemic reactions
3 documentedStandard SCIT safety protocols apply. Given the absence of published safety data for knotweed-specific SCIT, close monitoring and conservative build-up are particularly important in the rare cases where treatment is pursued.
SCIT vs Alternatives for Japanese Knotweed
For most patients presenting with 'knotweed allergy' during August–October: the appropriate treatment is for ragweed, not knotweed. For confirmed knotweed contact dermatitis: PPE and avoidance are the evidence-based approach.
| Criterion | SCIT (extremely rare)Best | Ragweed SCIT (far more likely indicated) | PPE + avoidance | Ragweed medications |
|---|---|---|---|---|
| Effectiveness | Unknown (no RCT) | High — 85% symptom reduction | High for contact reactions | Good — controls fall rhinitis |
| 5-yr cost | $3,500–$15,000 | $3,500–$15,000 | Low | $500–$3,000/5 yrs |
| Duration | 3–5 years | 3–5 years | Ongoing | Lifelong use |
| Convenience | At-home self-injection; weekly then monthly | Weekly then monthly clinic | Requires compliance | Daily medication |
| Safety | Good with monitoring | Excellent with monitoring | Excellent | Generally safe |
| Lasting effect | Unknown | Yes — 7–12+ yrs | Only during use | No |
SCIT (extremely rare)Best
Ragweed SCIT (far more likely indicated)
PPE + avoidance
Ragweed medications
For the vast majority of patients attributing fall symptoms to Japanese knotweed, ragweed SCIT is the appropriate intervention — Amb a 1 testing will confirm sensitization, and the 85% symptom reduction documented by Creticos 2006 NEJM makes ragweed the most evidence-supported fall weed immunotherapy available. Curex evaluates patient-reported knotweed allergy with serum-specific IgE testing, and delivers immunotherapy as a personalized at-home allergy shot kit — serum sterile-compounded to USP <797> for $129/month all-inclusive — only in the rare confirmed-sensitization case, typically alongside dock/sorrel to leverage limited Polygonaceae family evidence. Your first injection and every dose change are supervised live over Zoom by a board-certified allergist, with a prescribed epinephrine auto-injector confirmed on hand.
What Japanese Knotweed SCIT Actually Costs
Insurance coverage for knotweed SCIT would require documented IgE sensitization and a compelling clinical rationale. Given the near-absence of evidence and the insect-pollination biology, most insurers would likely require extensive pre-authorization documentation. Ragweed SCIT — the far more likely appropriate fall weed treatment — is covered under standard allergy immunotherapy benefits. Curex at-home IgE testing identifies specific japanese knotweed sensitization before allergist consultations, eliminating the need for an initial skin-test visit.
Cost range varies by deductible, co-insurance, and clinic.
Verify these codes with your insurer to confirm coverage.
Flat monthly subscription — includes consult, prescription, and at-home dosing for sublingual immunotherapy.
See if you qualifyStop guessing about your japanese knotweed allergy. Get a plan.
Take Curex’s 3-minute allergy quiz. A board-certified allergist will review your symptoms and recommend the right immunotherapy path for you — shots or drops.
Free quiz · Board-certified allergists · 50,000+ patients treated · HSA/FSA eligible
Japanese Knotweed SCIT — Frequently Asked
Quick answers to the questions patients ask most before starting treatment.
Almost certainly not. Japanese knotweed blooms from August through October — the exact same window as short ragweed, which is the most potent weed aeroallergen in North America, producing up to 1 billion pollen grains per plant that travel hundreds of miles. Knotweed is primarily pollinated by honeybees and bumblebees using insect-adapted pollen that is heavy and sticky, not aerially dispersed in clinically significant quantities. A systematic aerobiological study (Severova et al. 2022 Plant Ecol Evol) detects knotweed pollen in late-summer air samples but at low counts with uncertain clinical correlation. The correct diagnostic step for August–October rhinitis is Amb a 1 (short ragweed) component IgE testing — not knotweed IgE.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.